Literature DB >> 18791673

Perivalvular leakage 25 years after initial mitral valve replacement with a Björk-Shiley prosthesis.

Hiroya Minami1, Tatsuro Asada, Kunio Gan.   

Abstract

An 80-year-old woman had undergone initial mitral valve replacement using a Björk-Shiley mechanical valve owing to mitral stenosis 25 years earlier. Suddenly, she had anemia and an increased lactic dehydrogenase (LDH) level. Transesophageal echography (TEE) showed perivalvular leakage. In a redo operation, two side-by-side stitches of the valve on the posterior annulus were loosened without cutting and the sewing cuff at that site was floated over the annulus, leading to the perivalvular leakage. The valve was easily removed; and round, hard, degenerative calcified tissue composed of remnant mitral valve in the suture site during the initial operation was found just under the sewing cuff. After resection of this calcified round tissue, a 25-mm bioprosthesis was put in place. Her postoperative recovery was uneventful, and 47 days after surgery she was discharged without perivalvular leakage or anemia.

Entities:  

Mesh:

Year:  2008        PMID: 18791673     DOI: 10.1007/s11748-008-0275-2

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  9 in total

1.  Haemolytic anaemia of mechanical origin after open heart surgery.

Authors:  H M SAYED; J V DACIE; D A HANDLEY; S M LEWIS; W P CLELAND
Journal:  Thorax       Date:  1961-12       Impact factor: 9.139

2.  [Long-term results (6 to 17 years) of 372 mitral valve replacements using the Björk-Shiley prosthesis].

Authors:  G Fernandez; C Deville; S Horovitz; D Thibaud; F Fontan
Journal:  Ann Chir       Date:  1989

3.  Long-term clinical results after aortic valve replacement with the Björk-Shiley prosthesis.

Authors:  D Lindblom
Journal:  J Thorac Cardiovasc Surg       Date:  1988-04       Impact factor: 5.209

4.  Aortic aneurysm and aortic regurgitation following aortic valve replacement due to Takayasu's arteritis.

Authors:  Hiroya Minami; Noboru Wakita; Yujiro Kawanishi; Ikuro Kitano; Masahiro Sakata; Tsutomu Shida
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-01

5.  Medtronic Hall valve replacement in a third-world population group. A review of the performance of 1000 prostheses.

Authors:  M J Antunes; A Wessels; R G Sadowski; J G Schutz; K M Vanderdonck; J M Oliveira; L E Fernandes
Journal:  J Thorac Cardiovasc Surg       Date:  1988-06       Impact factor: 5.209

6.  Ten-year experience with the St. Jude Medical valve for primary valve replacement.

Authors:  L S Czer; A Chaux; J M Matloff; M A DeRobertis; S A Nessim; D Scarlata; S S Khan; R M Kass; T P Tsai; C Blanche
Journal:  J Thorac Cardiovasc Surg       Date:  1990-07       Impact factor: 5.209

7.  Late complications in patients with Björk-Shiley and St. Jude Medical heart valve replacement.

Authors:  D Horstkotte; R Körfer; L Seipel; W Bircks; F Loogen
Journal:  Circulation       Date:  1983-09       Impact factor: 29.690

8.  A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease.

Authors:  K E Hammermeister; G K Sethi; W G Henderson; C Oprian; T Kim; S Rahimtoola
Journal:  N Engl J Med       Date:  1993-05-06       Impact factor: 91.245

9.  [Surgical treatment of valvular heart disease associated with Behçet's disease].

Authors:  T Sugimoto; M Miyashita; T Ota; C Yamashita; M Okada; K Nakamura
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1990-11
  9 in total
  2 in total

1.  Pathogenesis of paravalvular leakage as a complication occurring in the late phase after surgery.

Authors:  Fumiaki Kuwabara; Akihiko Usui; Yoshimori Araki; Yuji Narita; Shinichi Mizutani; Hideki Oshima; Yuichi Ueda
Journal:  J Artif Organs       Date:  2011-04-20       Impact factor: 1.731

2.  Multiple paravalvular leak 17 years after a second mitral valve replacement.

Authors:  Tae-Eun Jung; Dong-Hyup Lee
Journal:  J Cardiothorac Surg       Date:  2013-02-15       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.